Paul Hagedoorn
- Pulmonary and Respiratory Medicine top 1%
- Food Science top 1%
- Pharmaceutical Science top 0.5%
- Physiology top 5%
- Electrical and Electronic Engineering top 10%
- Co-authors
- Henderik W. FrijlinkAnne H. de BoerDoetie GjaltemaFloris GrasmeijerMarcel HoppentochtJ. GoedeFrancesca ButtiniPascal Demoly
- Topics
- Inhalation and Respiratory Drug Delivery (70 papers)Asthma and respiratory diseases (22 papers)Cystic Fibrosis Research Advances (12 papers)
- Journals
- PLoS ONEAmerican Journal of Respiratory and Critical Care MedicineAdvanced Drug Delivery Reviews
- Partner nations
- NetherlandsSingaporeBelgium
In The Last Decade
Paul Hagedoorn
76 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 114
- Pulmonary and Respiratory Medicine 2.1k
- Food Science 607
- Pharmaceutical Science 507
- Physiology 500
- Electrical and Electronic Engineering 407
Countries citing papers authored by Paul Hagedoorn
This map shows the geographic impact of Paul Hagedoorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Hagedoorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Hagedoorn more than expected).
Fields of papers citing papers by Paul Hagedoorn
This network shows the impact of papers produced by Paul Hagedoorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Hagedoorn. The network helps show where Paul Hagedoorn may publish in the future.
Co-authorship network of co-authors of Paul Hagedoorn
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Hagedoorn. A scholar is included among the top collaborators of Paul Hagedoorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Hagedoorn. Paul Hagedoorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 12 | |
| 3 | 17 | |
| 4 | 12 | |
| 5 | 17 | |
| 6 | Characterisation of jet-milled and spray dried isoniazid for pulmonary administration | 1 |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 14 | |
| 10 | DESIGN AND DEVELOPMENT OF A DISPOSABLE HIGH DOSE DRY POWDER INHALER FOR AMINOGLYCOSIDES | 2 |
| 11 | THE INTERPLAY BETWEEN VARIABLES IN THE FORMULATION AND DISPERSION OF ADHESIVE MIXTURES FOR INHALATION | 1 |
| 12 | 61 | |
| 13 | 16 | |
| 14 | 7 | |
| 15 | 11 | |
| 16 | 3 | |
| 17 | 15 | |
| 18 | 23 | |
| 19 | 99 | |
| 20 | 20 |
About Paul Hagedoorn
Paul Hagedoorn is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Physiology, having authored 77 papers that have together received 2.4k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (70 papers), Asthma and respiratory diseases (22 papers) and Cystic Fibrosis Research Advances (12 papers). The work is most often cited by research in Pharmaceutical Science (507 citations), Pulmonary and Respiratory Medicine (2.1k citations) and Food Science (607 citations). Paul Hagedoorn has collaborated with scholars based in Netherlands, Singapore and Belgium. Frequent co-authors include Henderik W. Frijlink, Anne H. de Boer, Doetie Gjaltema, Floris Grasmeijer, Marcel Hoppentocht, J. Goede, Francesca Buttini, Pascal Demoly, Onno W. Akkerman and Harry Heijerman. Their work appears in journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.